Neurogenetics tests in Dubai & UAE

Compare available Neurogenetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

-1.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurogenetics test prices

Showing 1–15 of 68 matching tests.

Neurogenetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3746 APP Gene Alzheimer Disease Type 1 Genetic Test This test detects pathogenic mutations in the APP gene associated with early-onset familial Alzheimer's disease.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the APP gene", "Amyloid precursor protein gene mutations"] Parameters [] Preparation ["No specific fasting required", "Inform physician of all medications"] Indications ["Assessment of early-onset familial Alzheimer's disease risk", "Diagnosis in individuals with suggestive clinical presentation and family history"] Measurement technique Confirm with laboratory Codes LOINC: 21645-4 ICD-10: G30.0 Clinical summary This test detects pathogenic mutations in the APP gene associated with early-onset familial Alzheimer's disease.
TEST-3979 APP Gene Cerebral Amyloid Angiopathy (CAA) Genetic Test This diagnostic test evaluates the entire APP gene for pathogenic variants associated with hereditary cerebral amyloid angiopathy (CAA) and familial Alzheimer's disease.	Peripheral Blood or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the APP gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number changes"] Parameters [] Preparation ["No fasting required", "Complete mandatory pre-test genetic counselling", "Provide a three-generation family history"] Indications ["Diagnosis of hereditary cerebral amyloid angiopathy (CAA)", "Diagnosis of familial Alzheimer’s disease", "Risk assessment for individuals with a family history of CAA or Alzheimer's disease"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: I68.0 Clinical summary This diagnostic test evaluates the entire APP gene for pathogenic variants associated with hereditary cerebral amyloid angiopathy (CAA) and familial Alzheimer's disease.
TEST-5820 AR Gene Spinal & Bulbar Muscular Atrophy (SBMA) Genetic Test This genetic test evaluates the androgen receptor (AR) gene for CAG trinucleotide repeat expansions, which are the cause of Spinal and Bulbar Muscular Atrophy (SBMA).	Peripheral Whole Blood or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansions in the AR gene", "Presence of pathogenic variants in the AR gene"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counseling session recommended"] Indications ["Suspected diagnosis of Spinal and Bulbar Muscular Atrophy (SBMA)", "Family history of SBMA", "Differential diagnosis of motor neuron disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G12.2 Clinical summary This genetic test evaluates the androgen receptor (AR) gene for CAG trinucleotide repeat expansions, which are the cause of Spinal and Bulbar Muscular Atrophy (SBMA).
TEST-5693 ARHGEF10 Gene Slowed Nerve Conduction Velocity, Autosomal Dominant Genetic Test This test identifies pathogenic variants in the ARHGEF10 gene, which are responsible for autosomal dominant slowed nerve conduction velocity neuropathy.	Peripheral whole blood (5 mL EDTA), extracted DNA, or dried blood spot on FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARHGEF10 gene sequence", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Diagnosis of autosomal dominant inherited neuropathy with slowed nerve conduction velocity", "Family risk assessment for CMT2", "Confirmation of clinical suspicion based on nerve conduction studies"] Measurement technique Confirm with laboratory Codes LOINC: 51966-3 ICD-10: G60.0 Clinical summary This test identifies pathogenic variants in the ARHGEF10 gene, which are responsible for autosomal dominant slowed nerve conduction velocity neuropathy.
TEST-4908 ARID1A Gene Sequencing (Mental Retardation, Autosomal Dominant Type 14) Genetic Test2,800 AED · 2026 DHA Guidelines Test This genetic test analyzes the ARID1A gene to identify pathogenic variants associated with Coffin-Siris syndrome, a neurodevelopmental disorder.	Peripheral whole blood (3–5 mL EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARID1A gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions (within 14 days)"] Indications ["Suspected Coffin-Siris syndrome based on clinical presentation", "Family history of ARID1A-related disorders", "Need for definitive molecular diagnosis for genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.89 Clinical summary This genetic test analyzes the ARID1A gene to identify pathogenic variants associated with Coffin-Siris syndrome, a neurodevelopmental disorder.
TEST-4603 ARL13B Gene (Joubert Syndrome Type 8) Genetic Test This test identifies pathogenic variants in the ARL13B gene associated with Joubert syndrome type 8.	Whole Blood (Peripheral) – EDTA tube or FTA card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARL13B gene", "Single-nucleotide variants", "Small insertions/deletions", "Deep intronic mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Suspected Joubert syndrome type 8", "Family history of Joubert syndrome", "Characteristic brain MRI findings (molar tooth sign)"] Measurement technique Confirm with laboratory Codes LOINC: 83505-3 ICD-10: Q04.8, Q87.0 Clinical summary This test identifies pathogenic variants in the ARL13B gene associated with Joubert syndrome type 8.
TEST-4276 ARX Gene Early Infantile Epileptic Encephalopathy Type 1 Genetic Test This genetic test identifies mutations in the ARX gene associated with Early Infantile Epileptic Encephalopathy Type 1 (EIEE1).	Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARX gene sequence", "Copy Number Variants (CNVs) in ARX gene"] Parameters [] Preparation ["No specific fasting required", "Continue prescribed medications unless advised otherwise by physician"] Indications ["Suspected Early Infantile Epileptic Encephalopathy Type 1 (EIEE1)", "Neonatal-onset seizures with developmental delay"] Measurement technique Confirm with laboratory Codes LOINC: 81306-1 ICD-10: G40.4 Clinical summary This genetic test identifies mutations in the ARX gene associated with Early Infantile Epileptic Encephalopathy Type 1 (EIEE1).
TEST-4525 ARX Gene Sequencing (Hydranencephaly with Abnormal Genitalia / X‑Linked Lissencephaly Type 2) Genetic Test This genetic test sequences the ARX gene to identify pathogenic variants associated with specific neurodevelopmental disorders.	Whole blood, extracted DNA, or one drop on FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARX gene sequence", "Pathogenic variants (SNPs, indels, CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected ARX-related disorders", "Diagnosis confirmation", "Prognosis determination", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21641-2 ICD-10: Q04.2, Q04.8, Q87.0 Clinical summary This genetic test sequences the ARX gene to identify pathogenic variants associated with specific neurodevelopmental disorders.
TEST-5731 ASAH1 Gene Sequencing for Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME) Test This test detects pathogenic variants in the ASAH1 gene associated with Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME).	Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ASAH1 gene", "Copy Number Variations (CNV) in the ASAH1 gene"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed prior to sample collection"] Indications ["Suspected diagnosis of SMA-PME", "Patients with hallmark symptoms of myoclonus and motor regression"] Measurement technique Confirm with laboratory Codes LOINC: 81260-9 ICD-10: G12.1, G40.3 Clinical summary This test detects pathogenic variants in the ASAH1 gene associated with Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME).
TEST-5741 Ataxin-10 (ATXN10) Gene Spinocerebellar Ataxia Type 10 Autosomal Dominant Genetic Test This genetic test identifies the specific pentanucleotide repeat expansion in the ATXN10 gene associated with Spinocerebellar Ataxia Type 10 (SCA10).	Whole blood (3–5 mL in EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATXN10 gene pentanucleotide repeat expansion", "Pathogenic variant detection"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Clinical suspicion of hereditary ataxia", "Confirmed family history of SCA10", "Genetic counseling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G11.2 Clinical summary This genetic test identifies the specific pentanucleotide repeat expansion in the ATXN10 gene associated with Spinocerebellar Ataxia Type 10 (SCA10).
TEST-5440 ATP13A2 (PARK9) Gene Genetic Test This test evaluates the ATP13A2 gene for pathogenic variants associated with Kufor-Rakeb syndrome and early-onset Parkinson disease.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP13A2 gene sequence", "Pathogenic variants", "Copy Number Variations (CNV)"] Parameters [] Preparation ["No specific fasting required.", "Inform phlebotomist of all current medications."] Indications ["Diagnosis of Kufor-Rakeb syndrome", "Diagnosis of early-onset Parkinson disease", "Genetic counseling for families with ATP13A2-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81321-3 ICD-10: G23.8, G20 Clinical summary This test evaluates the ATP13A2 gene for pathogenic variants associated with Kufor-Rakeb syndrome and early-onset Parkinson disease.
TEST-5470 BSCL2 Gene Test This test detects pathogenic variants in the BSCL2 gene associated with Distal Hereditary Motor Neuropathy Type 5A (dHMN5A).	Whole Blood (EDTA), Extracted DNA, or Buccal Swab / FTA Card	10 to 14 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BSCL2 gene", "Coding exons and splice-site boundaries of the BSCL2 gene"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Suspected Distal Hereditary Motor Neuropathy Type 5A (dHMN5A)", "Differentiation from other motor neuron disorders"] Measurement technique Confirm with laboratory Codes LOINC: 77669-8 ICD-10: G12.29, G60.0 Clinical summary This test detects pathogenic variants in the BSCL2 gene associated with Distal Hereditary Motor Neuropathy Type 5A (dHMN5A).
TEST-5762 C19orf12 Gene (SPG43) Genetic Test This test identifies pathogenic variants in the C19orf12 gene associated with autosomal recessive hereditary spastic paraplegia type 43 (SPG43).	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C19orf12 gene", "Presence of mutations causing SPG43"] Parameters [] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Suspected diagnosis of Hereditary Spastic Paraplegia Type 43 (SPG43)", "Family history of SPG43", "Neurological symptoms consistent with SPG43"] Measurement technique Confirm with laboratory Codes LOINC: 83402-5 ICD-10: G11.4 Clinical summary This test identifies pathogenic variants in the C19orf12 gene associated with autosomal recessive hereditary spastic paraplegia type 43 (SPG43).
TEST-3795 C9orf72 Gene Amyotrophic Lateral Sclerosis with Frontotemporal Dementia Genetic Test This test identifies pathological hexanucleotide repeat expansions in the C9orf72 gene, a primary genetic cause of familial ALS and FTD.	Peripheral whole blood	3–4 Weeks (expedited option available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Hexanucleotide repeat expansions in the C9orf72 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions"] Indications ["Suspected familial ALS", "Suspected familial FTD", "Evaluation of genetic risk for ALS/FTD"] Measurement technique Confirm with laboratory Codes LOINC: 90520-1 ICD-10: G12.22, F02.80 Clinical summary This test identifies pathological hexanucleotide repeat expansions in the C9orf72 gene, a primary genetic cause of familial ALS and FTD.
TEST-4775 CASK Gene Genetic Test for Mental Retardation & Microcephaly with Pontocerebellar Hypoplasia This test identifies pathogenic variants in the CASK gene, which are associated with X-linked intellectual disability, microcephaly, and pontocerebellar hypoplasia.	Peripheral whole blood (EDTA) or dried blood spot (FTA card)	3 – 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CASK gene", "Single nucleotide variants", "Small insertions and deletions", "Copy-number variants"] Parameters [] Preparation [] Indications ["Individuals with unexplained intellectual disability, developmental delay, microcephaly, cerebellar hypoplasia, or pontocerebellar hypoplasia.", "At-risk family members of a proband with a known CASK pathogenic variant."] Measurement technique Confirm with laboratory Codes LOINC: 81261-4 ICD-10: Q04.8, Q02, F70 Clinical summary This test identifies pathogenic variants in the CASK gene, which are associated with X-linked intellectual disability, microcephaly, and pontocerebellar hypoplasia.

Category overview

Neurogenetics: overview

Securing a deep, fundamental understanding of your family's neurological blueprint allows for proactive, highly informed medical decisions that protect your long-term cognitive and motor vitality. As the core of our advanced neuro-diagnostic laboratory services, the Neurogenetics department utilizes state-of-the-art sequencing and targeted DNA analysis to uncover the precise genetic mutations driving rare brain, spinal cord, and peripheral nerve diseases. By leveraging advanced molecular technology, this expansive profiling helps establish an absolute diagnosis for elusive conditions, safely guiding your healthcare provider in tailoring highly personalized precision medicine, supportive therapies, and proactive family planning. Trusted for clinical rigor across premier diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical accuracy, and incredibly prompt turnaround times. Take an empowered step toward targeted neurological support—schedule your neurogenetics testing in UAE, coordinate a seamless clinic or home sample collection, or connect with our specialized specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.